Clinical Trial Update: Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing induction therapy for lupus nephritis with oral corticosteroids plus mycophenolate mofetil (MMF) versus obinutuzumab plus MMF; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Lupus Nephritis, Systemic Lupus Erythematosus (SLE) | Phase 3 | Status: RECRUITING